Andrew R Allen's Net Worth
$10.5 Million
Who is Andrew R Allen?
Andrew R Allen has an estimated net worth of $10.5 Million. This is based on reported shares across multiple companies, which include Gritstone bio, Inc., PHARMION CORP, Sierra Oncology, Inc., Clovis Oncology, Inc., TCR2 THERAPEUTICS INC., Epizyme, Inc., and Adaptimmune Therapeutics PLC.
SEC CIK
Andrew R Allen's CIK is 0001374539
Past Insider Trading and Trends
2023 was Andrew R Allen's most active year for acquiring shares with 8 total transactions. Andrew R Allen's most active month to acquire stocks was the month of June. 2008 was Andrew R Allen's most active year for disposing of shares, totalling 11 transactions. Andrew R Allen's most active month to dispose stocks was the month of February. 2008 saw Andrew R Allen paying a total of $297,891.58 for 4,113 shares, this is the most they've acquired in one year. In 2015 Andrew R Allen cashed out on 160,000 shares for a total of $10,521,188.32, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Gritstone bio, Inc. (GRTS) Snapshot price: $0.47
PRESIDENT AND CEOAndrew R Allen owns 985,360 units of Common Stock which is worth $463,119.20. From 2022 to 2024 Andrew R Allen acquired a total of 1,009,623 shares in Gritstone bio, Inc., Andrew also disposed a total of 349,263 shares of Gritstone bio, Inc. equalling to $18,156.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -23.55% | -650.00K |
—
|
—
| 2.11M |
Jun 24
| |||
Form 4
| +2.45% | 23.61K |
$0.75 | -$18,156.00 | 985.36K |
May 15 - May 16
| |||
Form 4
| +13.22% | 105K |
—
|
—
| 899.35K |
Feb 1
| |||
Form 4
| +624.83% | 738.55K |
—
|
—
| 856.75K |
Feb 2
| |||
Form 4
| +145.23% | 70K |
—
|
—
| 118.2K |
Jan 31
| |||
Form 4
|
∞
| 48.2K |
—
|
—
| 48.2K |
Jan 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PHARMION CORP No price found
Chief Medical Officer, EVPAndrew R Allen used to own units in Common Stock but no longer holds any shares there.acquired a total of 5,900 shares in PHARMION CORP at a cost of $383,286.70, Andrew also disposed a total of 5,900 shares of PHARMION CORP equalling to $30,430.72.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -1.15K |
$72.43 | $297,891.58 |
0
|
Mar 1 - Mar 7
| |||
Form 4
| +14.43% | 145 |
$63.98 | $9,277.10 | 1.15K |
Dec 6
| |||
Form 4
| +25.00% | 201 |
$63.26 | $12,715.26 | 1K |
Dec 1
| |||
Form 4
|
∞
| 804 |
$41.01 | $32,972.04 | 804 |
Sep 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Sierra Oncology, Inc. No price found
InvestorAndrew R Allen used to own units in Common Stock but no longer holds any shares there. From 2017 to 2022 Andrew R Allen acquired a total of 66,000 shares in Sierra Oncology, Inc. at a cost of $108,240.00, Andrew also disposed a total of 1,650 shares of Sierra Oncology, Inc. equalling to $90,750.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -1.65K |
$55.00 | -$90,750.00 |
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
∞
| 66K |
$1.64 | $108,240.00 | 66K |
Dec 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Clovis Oncology, Inc. No price found
See RemarksAndrew R Allen owns 101,919 units of Common Stock. In the year 2011 Andrew R Allen filed a total of 9 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 2
| |||
Form 4/A
| -43.98% | -80.00K |
$65.87 | -$5,269,895.80 | 101.92K |
Scheduled
|
Jan 15 - Jan 16
| ||
Form 4
| -43.98% | -80.00K |
$65.64 | -$5,251,292.52 | 101.92K |
Scheduled
|
Jan 15 - Jan 16
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 10
| |||
Form 4
| -100.00% | -22.59K |
$68.54 | -$1,548,683.10 |
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
| +10.86% | 21.85K |
$13.00 |
—
| 223K |
Nov 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TCR2 THERAPEUTICS INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||